Author: ACN Editorial Staff | Photo: Retrieved from Cubadebate . Published in Health.
Havana, October 12 (ACN) A Clinical Studies of Quimi-VioIt is a vaccine candidate to prevent pneumonia, meningitis, otitis media and sepsis caused by Streptococcus pneumoniae or pneumococcus, and has been started to be used in 32 polyclinics in all cities across the country. Havana.
The vaccine candidate produced by the Finlay Vaccine Institute (IFV) is suitable for pediatric populations with chronic diseases, the Cubadebate website reported today.
The study has been approved by the Cuban Center for the Control of Medicines, Equipment and Medical Devices (Cecmed) and is led by the Havana Provincial Center of Health and Epidemiology and the Vaccination Program; and is conducted by the National Coordinating Center for Clinical Trials (Cecncec).
Quimi-Vio is a heptavalent conjugate vaccine that protects against the world’s most prevalent bacterial serotypes. It is based on a conjugate vaccine platform that is widely used and known for its safety and efficacy in the pediatric population.
Dr. Meybi Rodríguez, director of clinical trials at IFV, said Quimi-Vio has completed all stages of clinical evaluation and proven that it is a safe and effective vaccine for preventing pneumococcal disease.
It began clinical evaluation in children in 2013 and is currently in the final stages of development applying for registration with the regulatory agency Cecmed.
The clinical development of Quimi-Vio was funded by the Financial Fund for Science and Innovation (Fonci) of the Ministry of Science, Technology and the Environment (Citma).
Last September, a community intervention study was launched in Cienfuegos, in which 90% of the population aged 1-5 years was vaccinated.
This study is a continuation of a similar study conducted by the province from 2017 to 2018, which achieved 92 per cent coverage and could assess the impact on reducing hospitalizations for invasive pneumococcal disease by more than 62 per cent. Fegos territory,” Rodriguez said.
According to the World Health Organization, pneumonia is the single largest cause of death among children in the world, and pneumococcal disease particularly affects children under the age of five.
Pneumonia can be caused by viruses, bacteria, or fungi, with Streptococcus pneumoniae being the most common cause of bacterial pneumonia in children.